Carregant...
Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer
INTRODUCTION: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib and gefitinib have shown equal efficacy in terms of response rates and overall su...
Guardat en:
| Publicat a: | Indian J Med Paediatr Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5398099/ https://ncbi.nlm.nih.gov/pubmed/28469331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5851.203502 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|